Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Disorders of the Nervous System

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice

Lauren Lepeak, Sophia Miracle, Antonio Ferragud, Mariel P. Seiglie, Samih Shafique, Zeynep Ozturk, Margaret A. Minnig, Gianna Medeiros, Pietro Cottone and Valentina Sabino
eNeuro 1 December 2023, 10 (12) ENEURO.0424-23.2023; https://doi.org/10.1523/ENEURO.0424-23.2023
Lauren Lepeak
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Miracle
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Ferragud
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariel P. Seiglie
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samih Shafique
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeynep Ozturk
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret A. Minnig
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianna Medeiros
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pietro Cottone
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Sabino
Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University Chobanian & Avedisian, School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Alcohol use disorder (AUD) is a complex psychiatric disease characterized by periods of heavy drinking and periods of withdrawal. Chronic exposure to ethanol causes profound neuroadaptations in the extended amygdala, which cause allostatic changes promoting excessive drinking. The bed nucleus of the stria terminalis (BNST), a brain region involved in both excessive drinking and anxiety-like behavior, shows particularly high levels of pituitary adenylate cyclase-activating polypeptide (PACAP), a key mediator of the stress response. Recently, a role for PACAP in withdrawal-induced alcohol drinking and anxiety-like behavior in alcohol-dependent rats has been proposed; whether the PACAP system of the BNST is also recruited in other models of alcohol addiction and whether it is of local or nonlocal origin is currently unknown. Here, we show that PACAP immunoreactivity is increased selectively in the BNST of C57BL/6J mice exposed to a chronic, intermittent access to ethanol. While pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor-expressing cells were unchanged by chronic alcohol, the levels of a peptide closely related to PACAP, the calcitonin gene-related neuropeptide, were found to also be increased in the BNST. Finally, using a retrograde chemogenetic approach in PACAP-ires-Cre mice, we found that the inhibition of PACAP neuronal afferents to the BNST reduced heavy ethanol drinking. Our data suggest that the PACAP system of the BNST is recruited by chronic, voluntary alcohol drinking in mice and that nonlocally originating PACAP projections to the BNST regulate heavy alcohol intake, indicating that this system may represent a promising target for novel AUD therapies.

  • addiction
  • alcohol
  • ethanol
  • anxiety
  • dependence
  • neuropeptide

Significance Statement

Our results point at a key role for the neuropeptide PACAP (pituitary adenylate cyclase-activating polypeptide), specifically of the bed nucleus of the stria terminalis, in mediating heavy alcohol drinking in mice. This system may, therefore, represent a novel target for the treatment of alcohol use disorders.

Introduction

Alcohol is the most common addictive substance in the world (see National Survey on Drug Use and Health, Table 5.4A—Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2017 and 2018; available at: www.samhsa.gov). Every year, excessive alcohol use costs the United States $249 billion and causes 88,000 deaths, as well as various chronic diseases and social issues (Sacks et al., 2015). Alcohol use disorder (AUD), a highly prevalent, chronic, relapsing disorder, affects >14 million people in the United States alone, in addition to being severely undertreated, with only three modestly effective pharmacological therapies available (see National Survey on Drug Use and Health, Table 5.4A—Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2017 and 2018; available at: www.samhsa.gov; Reus et al., 2018; Koob, 2021; Mason and Heyser, 2021).

Chronic exposure to ethanol has been shown to produce profound neuroadaptations in specific brain regions, including the recruitment of key stress neurotransmitters, ultimately causing allostatic changes that sustain excessive drinking (Koob, 2003, 2009; Breese et al., 2011). The bed nucleus of the stria terminalis (BNST) is a brain structure critically involved in the behavioral response to stress as well as in chronic, pathologic ethanol use (Kash et al., 2009, 2015; Pleil et al., 2015; Avery et al., 2016; Koob and Volkow, 2016; Lebow and Chen, 2016; Pati et al., 2020). Chronic ethanol causes hyperexcitability of and increased glutamatergic drive onto neurons of the laterodorsal BNST (BSTld), whose stimulation, in turn, results in an anxious phenotype, which may drive excessive drinking (Kash et al., 2009; Wills et al., 2012; Kim et al., 2013; Marcinkiewcz et al., 2015; Pleil et al., 2015; Marcinkiewcz et al., 2016).

The BSTld expresses an extraordinary amount of peptides, suggesting that diverse neuronal inputs may encode different signals allowing for fine-tuning of behavior (Kash et al., 2015). Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38 aa neuropeptide belonging to the secretin/glucagon/vasoactive intestinal polypeptide family, whose fibers, of nonlocal origin, are highly abundant in the BSTld (Ghatei et al., 1993; Piggins et al., 1996; Hannibal et al., 2002; Hammack et al., 2009; Missig et al., 2014; Stamatakis et al., 2014). PACAP is a key mediator of the stress response (Hashimoto et al., 2001; Agarwal et al., 2005; Stroth and Eiden, 2010; Ressler et al., 2011; Gaszner et al., 2012; Dore et al., 2013; Lehmann et al., 2013); PACAP administration elicits anxiety-like and anhedonic-like behavior (Dore et al., 2013; Missig et al., 2014; Lezak et al., 2014a; Hammack and May, 2015; Seiglie et al., 2015; Iemolo et al., 2016), and several types of stressors recruit the PACAP system, especially that of the BNST (Hannibal et al., 1995; Hammack et al., 2009; Stroth and Eiden, 2010; Kocho-Schellenberg et al., 2014; Missig et al., 2014; Lezak et al., 2014a; Seiglie et al., 2019; Varodayan et al., 2020; Seiglie et al., 2022).

Suggesting a likely involvement of the PACAP system in AUD, a single nucleotide polymorphism of the PACAP gene was found to be linked to high alcohol intake in a European population (Kovanen et al., 2010); furthermore, a specific genotype of the type I PACAP receptor (PAC1R) is associated with problematic alcohol use in women (Dragan et al., 2017). In the preclinical realm, the PACAP/PAC1R system has also been shown to be involved in the actions of alcohol by pharmacological and genetic deletion studies (Feany and Quinn, 1995; Tanaka et al., 2004, 2010; Gargiulo et al., 2020; Minnig et al., 2021, 2022). In particular, in the BNST, it has recently been shown that rats made dependent via chronic exposure to alcohol vapors display increased levels of PACAP, and that the pharmacological antagonism of PAC1R in this area is able to block dependence-induced excessive alcohol intake as well as anxiety-like behavior in these rats (Ferragud et al., 2021).

Whether the PACAP system of the BNST is also recruited in other models of alcohol addiction is currently unknown. Here, we first assessed PACAP immunoreactivity in the BNST of mice exposed for several weeks to chronic, intermittent access to ethanol. In the same model, we also measured the number of PAC1R-expressing cells and the levels of a peptide closely related to PACAP, the calcitonin gene-related neuropeptide (CGRP). We then used a retrograde approach to test the effect of chemogenetically inhibiting PACAP neuronal afferents to the BNST on ethanol consumption in the same model. Our data suggest that the PACAP system of the BNST is recruited by chronic, voluntary alcohol drinking in mice and that nonlocally originating PACAP projections to the BNST regulate heavy alcohol intake.

Materials and Methods

Subjects

Male and female C57BL/6J mice (7 weeks old on arrival) were purchased from The Jackson Laboratory. Group 1 was used for the time course and the PACAP immunohistochemistry (IHC; n = 20 for time course; n = 23 for the PACAP BNST IHC), group 2 was used for the PAC1R BNST IHC (n = 26), and group 3 was used for CGRP BNST IHC (n = 25). Male and female Pacap-ires-Cre mice, a gift from Bradford Lowell (Harvard Medical School, Boston, MA; Krashes et al., 2014; Ross et al., 2018) were bred in house onto a C57BL/6J background. Group 4 was used for the chemogenetic experiment (n = 20). Mice were housed in an AAALAC-approved vivarium on a 12 h reverse light/dark cycle, with ad libitum access to water and regular rodent corn-based chow (Teklad Irradiated Global Rodent Diet 2918). Male and female mice were housed in the same vivarium room, though at a distance from each other. Experiments were conducted during the dark cycle of the animals. Procedures adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and The Principles of Laboratory Animal Care (eighth edition) and were approved by the Institutional Animal Care and Use Committee.

Drugs

Ethanol solution (20% v/v) was obtained by diluting 200 proof ethanol in tap water. Clozapine-N-Oxide (CNO) was provided courtesy of Kenner Rice (National Institutes of Health) and was dissolved in sterile saline.

Mouse intermittent access to two-bottle choice

Fifty milliliter conical tubes (Thermo Fisher Scientific) equipped with rubber stoppers and 2.5 inch straight metal-ball bearing sipper tubes (Ancare) were used for the delivery of solutions and were placed on top of the home cages. Mice were then given intermittent access using an intermittent access to two-bottle choice (IA2BC) paradigm for the entire duration of the experiments, during which time one water bottle was replaced with a bottle containing 20% (v/v) ethanol on alternating days for 24 h, as done previously (Hwa et al., 2011; Navarro et al., 2019; Quadir et al., 2020). Briefly, at the beginning of the dark cycle, preweighed bottles (one ethanol, one water) were provided, and 24 h later both bottles were removed and weighed again to calculate intake. Water controls received identical treatment, except that the bottles were filled with tap water. Additional cages and sets of bottles were used to ensure negligible spillage during cage handling. All groups of mice were exposed to the IA2BC paradigm.

Brain tissue preparation

Mice for IHC or fluorescence in situ hybridization (FISH) were deeply anesthetized and transcardially perfused with PBS followed by 4% paraformaldehyde (PFA). Brains were removed, postfixed at 4°C for 24 h, and then transferred to 30% sucrose at least until saturation. Brain sections were cut using a cryostat into 30 or 14 μm sections for IHC or FISH, respectively. For IHC, sections were stored in a cryoprotectant solution at −20°C until processed; for FISH, sections were mounted directly on slides, then dried at −20°C for 2 h, and finally stored at −80°C until the assay was performed.

Immunohistochemistry

PACAP IHC

Every fourth section (120 μm apart) of the BNST region (range, +0.38 to +0.02 mm from bregma) and every sixth section (180 μm apart) of the CeA region (range, −0.82 to −1.70 mm from bregma) were collected systematically and processed for IHC. Free-floating sections were washed in Tris-buffered saline (TBS) after every incubation. After rinsing, free-floating sections were incubated in a 0.3% hydrogen peroxide TBS solution to quench endogenous peroxidases, followed by additional rinsing and a blocking step (3% normal goat serum in 0.4% Triton X-100). Sections were then incubated in anti-PACAP primary antibody [1:1000; catalog #T-4473, Bachem (RRID: AB_519166); Piggins et al., 1996; Norrholm et al., 2005; Das et al., 2007; Csati et al., 2012; Nakamura et al., 2014; Matsumoto et al., 2016; Steinberg et al., 2016; Liu and Wong-Riley, 2019; Meloni et al., 2019] in blocking solution for 24 h at 4°C. Sections were then incubated in a biotinylated anti-rabbit secondary antibody (1:500; Vector Laboratories) in blocking solution for 2 h at room temperature (RT). Sections were then incubated in secondary antibody (1:500; biotinylated anti-rabbit, Vector Laboratories) in blocking solution for 2 h at room temperature, and, finally, incubated in an avidin–biotin horseradish peroxidase ABC complex solution (Vector Laboratories) in blocking solution for 1 h. Sections were then processed using a diaminobenzidine (DAB) substrate kit (Vector Laboratories) until reaction was complete, mounted onto slides, and allowed to dry overnight. The following day, slides were dehydrated and coverslipped using DPX Mountant (Electron Microscopy Sciences).

PAC1R and CGRP IHC

Every fourth section (120 μm apart) of the BNST region (range, +0.38 to +0.02 mm from bregma) was processed. Free-floating sections were washed in TBS after every incubation. Following initial TBS washes, 10 mm sodium citrate buffer, pH 6, antigen retrieval was performed at 80°C for 30 min. Sections were blocked with a blocking solution (3% normal goat serum in 0.2% Triton X-100 in TBS) for 1 h at RT, followed by incubation with primary antibody [1:250, for 48 h at 4°C; anti-PAC1R; catalog #AVR-003 Alomone Labs (RRID: AB_2756805); 1:250, for 24 h at 4°C; anti-CGRP; catalog #ab81887, Abcam (RRID: AB_1658411)]. Sections were then incubated with secondary antibody (for PAC1R: 1:200; anti-rabbit; catalog #AF555, Thermo Fisher Scientific; for CGRP: anti-mouse; 1:250; catalog #AF488, Thermo Fisher Scientific). Sections were then washed in TBS and coverslipped with DAPI-containing mounting medium (VECTASHIELD Antifade Mounting Medium with DAPI, Vector Laboratories).

Quantification

PACAP density quantification

To assess PACAP immunoreactivity, chromogen PACAP pictures were taken in bright field at a 10× magnification under a preset exposure and gain to standardize the images. For each image, area contours were drawn corresponding to the laterodorsal subdivision (oval nucleus) of the BSTld or the capsular subdivision (CeC) and lateral subdivision (CeL) of the central nucleus of the amygdala (CeA) along the entire bregma range, with a microscope (model BX-51, Olympus) equipped with a live video camera (model Retiga 2000R, QImaging) and a three-axis motorized stage (model MAC6000 XYZ, Ludl Electronics). Densitometry analysis was then performed using the ImageJ software (NIH), where images were converted to 8 bit and adjusted using the autothreshold Triangle algorithm. Once converted, the mean optical density of signal was calculated by subtracting the background signal and then by normalizing the value to the traced area. The final number of brains was n = 23 for PACAP BNST and n = 29 for PACAP CeA IHC from n = 32 (only brains with good staining and tissue quality were used).

CGRP density quantification

To assess CGRP immunoreactivity, fluorescent pictures of sections containing the BSTld were captured as described above, while imaging parameters were held constant for all images. Three digital squares were placed randomly within the staining region, and the mean labeling intensity of the three squares was determined. The final number of brains was n = 26 for CGRP BNST IHC.

PAC1R-positive cell quantification

The number of PAC1R-expressing cells was quantified using an unbiased stereological approach as previously described (Ferragud et al., 2020, 2021; Minnig et al., 2021). The BSTld was outlined with an Olympus PlanApo N 2× objective (numerical aperture, 0.08), and counting was done using an Olympus UPlanFL N 20× objective (numerical aperture, 0.75). Counts were performed by an experimenter blind to conditions using a grid and a counting frame of 250 × 250 μm, a guard zone of 2 μm, and a dissector height of 20 μm in the Optical Fractionator Workflow module in Stereo Investigator. The final number of brains was n = 25 for PAC1R BNST IHC.

Stereotaxic surgery

Pacap-ires-Cre mice were 7–10 weeks of age at the time of surgery. Surgeries were performed using a Kopf stereotaxic frame, using isoflurane for anesthesia. BNST coordinates were as follows: anteroposterior, +0.85; mediolateral, ±0.90; dorsoventral, –4.10 (from skull). A retrograde adeno-associated virus (AAV) expressing a Cre-dependent inhibitory designer receptor exclusively activated by designer drugs (DREADD), AAVrg-hSyn-DIO-hM4D(Gi)-mCherry, was delivered bilaterally into the BNST (0.3 μl/side) via a 22 gauge syringe (2 μl neurosyringe, Hamilton) over the course of 5 min, with an additional 5 min wait to avoid backflow. Approximately 1 week after surgery, the IA2BC paradigm began, and drug testing began ∼7 weeks after surgery (after 6 weeks of ethanol drinking). At the end of testing (∼13 weeks after surgery), mice were killed by isoflurane anesthesia, and brains were collected after transcardial perfusion for brain histology.

Clozapine-N-oxide administration

For DREADD experiments, CNO was administered intraperitoneally (0, 1, and 3 mg/kg, in a volume of 10 ml/kg in saline) 30 min before the beginning of the drinking session, using a within-subject Latin-square design. Mice were allowed at least one treatment-free drinking session between test days. CNO is a pharmacologically inert metabolite of the atypical antipsychotic clozapine; although there is a slight risk of CNO back-metabolizing to clozapine, studies have shown that it has little or no pharmacological activity in mice and rats when administered at the recommended doses (Urban and Roth, 2015), and previous studies have shown that CNO itself does not impact alcohol intake (den Hartog et al., 2016; Kreifeldt et al., 2022; Flanigan et al., 2023; Griffin et al., 2023; Zamudio et al., 2023). Alcohol, water, and food weights were recorded at 2, 6, and 24 h, common time points used in the literature (Sabino et al., 2013; Newman et al., 2018; Quadir et al., 2021a, b).

Histology in DREADD mice

Mice were deeply anesthetized with isoflurane and transcardially perfused with ice-cold heparinized PBS, followed by 4% paraformaldehyde. Brains were extracted, allowed to fix in 4% paraformaldehyde for 24 h, and then placed in 30% sucrose for cryoprotection. Brains were sliced at 30 μm on a cryostat and then stored at −20°C in cryoprotectant. Sections containing the BNST were mounted on slides and coverslipped with VECTASHIELD Antifade Mounting Media, and the injection tract was verified under a microscope. A few slices containing the lateral parabrachial nucleus (LPB) were also collected to verify successful retrograde transport of the virus (mCherry expression) in an upstream area as well as to verify the specificity of the virus for PACAP neurons (see next paragraph).

Fluorescence in situ hybridization

RNAscope Multiplex Fluorescent Reagent Kit version 2 (ACD) was used following the manufacturer instructions. Slides were first baked at 60°C for 30 min, fixed in 4% PFA, and dehydrated in ethanol. Sections were then incubated with hydrogen peroxide (10 min, RT), then boiled in target retrieval solution for 5 min and surrounded by a hydrophobic barrier (ImmEdge Pen, Vector Laboratories). Sections were incubated in Protease Plus (30 min, RT), followed by incubation with target probes (Adcyap1, catalog #405911; Tac1, catalog #410351; mCherry, catalog #431201; all from ACD) for 2 h at 4°C. Signal was then amplified using amplifiers AMP1-3. Following amplification, each probe was assigned a TSA Plus fluorophore (FITC, Cy3, Cy5; for 30 min at 40°C) and corresponding channel (C1, C2 and C3, 15 min at 40°C), each channel step concluding with an HRP blocker. Sections were incubated in DAPI for 30 s at RT and then coverslipped in mounting medium (Vectashield Hardset AntiFade Mounting Medium, Vector Laboratories). Slides were imaged using a VS120 Virtual Slide Scanner (Olympus) at a 20× magnification. Images were then processed using QuPath version 0.4.3 software.

Statistical analysis

Data from the IHC studies were analyzed using either two-way ANOVAs (Sex and Group as between-subjects factors) or with Student’s t tests when sexes were pooled. Data from the alcohol-drinking study were analyzed using two-way ANOVAs (Dose of CNO and Time as within-subject factors). Pairwise post hoc comparisons were made using the Student–Newman–Keuls test or a Student’s t test when comparing two groups. Significance was set at p < 0.05. The software/graphic packages used were StatSoft Statistica 12 and GraphPad Prism 8.

Results

Acquisition of drinking in males and female C57BL/6J mice in IA2BC paradigm

C57BL/6J mice given intermittent access to 20% v/v ethanol and water (IA2BC) increased their intake of alcohol across the time of observation (6 weeks), as shown in Figure 1 (Session: F(17,306) = 5.59, p < 0.001). Female mice showed significantly higher ethanol intake compared with male mice (Sex: F(1,18) = 124.51, p < 0.001; Sex * Session: F(17,306) = 2.57, p < 0.001), as shown in Figure 1A. Female mice rapidly increased their ethanol drinking behavior (escalation), with a significant difference between sexes evident already on day 3. The average ethanol intake in session 18 was 20.9 and 12.2 g/kg in females and males, respectively. Intake of water decreased across time (Session: (F(17,306) = 4.10, p < 0.001) consistently in both sexes [Sex: F(1,18) = 0.077; not significant (n.s.); Sex * Session: F(17,306) = 0.51, n.s.; Fig. 1B]; the average water intake in session 18 was 54.5 and 60.5 ml/kg in females and males, respectively. Total fluid intake was also higher in female mice (Sex: F(1,18) = 77.78, p < 0.001; Sex * Session: F(17,306) = 1.63, p = 0.055), as shown in Figure 1C; the average total fluid intake in session 18 was 186.7 and 137.5 ml/kg in females and males, respectively. Ethanol preference was also higher in female mice throughout the observation period (Sex: F(1,18) = 17.02, p < 0.001; Sex * Session: F(17,306) = 1.05, n.s.); the average preference for ethanol in session 18 was 71.4% and 56.7% in females and males, respectively.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Male and female C57BL/6 mice were exposed to intermittent access to alcohol (IA2BC; Monday, Wednesday, Friday, 24 h/d, 20% v/v ethanol vs water) for 6 consecutive weeks or 18 drinking sessions. A, C, D, Female mice drank more alcohol than males (A), drank more fluids (C), and showed a higher preference for alcohol (D). B, Water intake did not significantly differ between sexes. Data represent the mean ± SEM (n = 10/group, total 20 mice). a, p < 0.05; b, p < 0.01; c, p < 0.001; versus males.

Chronic, intermittent ethanol drinking increases PACAP levels in the BNST

After 7 weeks of IA2BC access, IA2BC and control mice were killed 24 h after the last drinking session. Brain slices were processed for PACAP IHC and DAB staining quantified by densitometry. Average ethanol intake during the last session in these animals was as follows: males, 12.1 ± 1.0 g/kg; females, 20.3 ± 1.5 g/kg. As shown in Figure 2A, mice with a history of chronic, intermittent alcohol drinking displayed higher levels of PACAP in the BNST in both male and female mice (Ethanol: F(1,19) = 34.38, p < 0.001; Ethanol * Sex: F(1,19) = 0.06, n.s.). A main effect of Sex was also observed, with female mice showing higher levels of PACAP in this region (Sex: F(1,19) = 40.13, p < 0.001). Figure 2B shows the data not dissociated by sex; IA2BC overall caused a 33.5% increase in PACAP levels in the BSTld. As previously shown, across the anterior–posterior axis of the BNST, the majority of PACAP immunoreactivity was found in the BSTld (Missig et al., 2014; Seiglie et al., 2019; Jiang et al., 2023), and the PACAP immunohistochemical staining pattern was found to be limited to incoming fibers, with no local cell bodies labeled. On the other hand, no statistically significant increase in PACAP immunoreactivity was observed in the CeA (capsular and lateral subdivisions) of IA2BC mice compared with controls, as shown in Extended Data Figure 2-1, although a trend to an Ethanol * Sex interaction could be observed (p = 0.08).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

A, PACAP immunoreactivity levels are elevated in the BSTld of male and female C57BL/6J mice exposed to intermittent access to alcohol (IA2BC; EtOH), compared with control, water-only mice (Ctrl). B, Data are reported with the two sexes pooled. C, D, Representative PACAP staining (DAB) in mouse BNST of a Ctrl and an EtOH subject, respectively. Magnification, 10×. Scale bar, 200 μm. Mice were killed after 7 weeks of IA2BC, 24 h after the end of the last drinking session. BSTlp, BNST lateral-posterior; BSTlj, BNST lateral-justacapsular. Data represent the mean ± SEM (A, n = 10–13/group; B, n = 5–8/group; total, 23 mice). ***p < 0.001 versus Ctrl. Extended Data Figure 2-1 shows the effect of IA2BC on PACAP immunoreactivity in the CeA.

Figure 2-1

A, PACAP levels are unaltered in the CeA of male and female C57BL/6J mice exposed to intermittent access to alcohol (IA2BC; EtOH), compared with control, water-only mice (Ctrl). B, Data are reported with the two sexes pooled. C, D, Representative PACAP staining (DAB) in mouse BNST of a Ctrl and an EtOH subject, respectively. Magnification, 10×. Scale bar, 200 μm. Mice were killed after 7 weeks of IA2BC, 24 h after the end of the last drinking session. CeM, CeA medial. Data represent the mean ± SEM (A, n = 14–15/group; B, n = 6–8/group). Download Figure 2-1, TIF file.

Chronic, intermittent ethanol drinking does not affect the number of PAC1R-positive cells in the BNST

IA2BC and control mice were killed 24 h after the last drinking session. Brain slices were processed for PAC1 IHC, and immunofluorescent staining was quantified by cell counting. Average ethanol intake during the last session in these animals was as follows: males, 15.2 ± 1.4 g/kg; females, 21.5 ± 1.2 g/kg. No difference in the number of PAC1R-positive cells was found in the BSTld between mice with a history of chronic, intermittent ethanol drinking and control mice in either sex (Ethanol: F(1,22) = 0.53, n.s.; Ethanol * Sex: F(1,22) = 0.003, n.s.). Figure 3A shows the data after pooling the two sexes. PAC1R immunoreactivity was found to be present also in the other subdivisions of the dorsal BNST, where similarly no group differences were found (data not shown).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

A, The number of PAC1R-immunoreactive cells is not altered in the BNST of IA2BC mice. B, C, Representative PAC1R staining (fluorescence) in mouse BNST of a Ctrl and an EtOH subject, respectively. Magnification, 10×. Scale bar, 200 μm. D, CGRP levels are elevated in the BSTld of IA2BC mice (EtOH), compared with control mice (Ctrl). E, F, Representative CGRP staining (fluorescence) in mouse BNST of a Ctrl and an EtOH subject, respectively. Magnification, 10×. Scale bar, 200 μm. Mice were killed 24 h after the end of the last IA2BC session. BSTlp, BNST lateral-posterior; BSTlj, BNST lateral-justacapsular. Data represent the mean ± SEM (A, n = 11–15/group; D, n = 10–15/group; total, 26 mice). *p < 0.05 versus Ctrl.

Chronic, intermittent ethanol drinking increases CGRP levels in the BNST

Since PACAP immunoreactivity significantly overlaps with that of CGRP in the fibers of extended amygdala (Missig et al., 2014), we assessed whether IA2BC mice also displayed increased CGRP levels in the BNST. Average ethanol intake during the last session in these animals was as follows: males, 13.6 ± 1.3 g/kg; females, 20.7 ± 2.1 g/kg. We observed that BNST CGRP expression was highest within the BSTld, and that its localization closely mimics PACAP expression in this area, as previously shown. IA2BC mice displayed higher levels of CGRP in the BSTld in both sexes (Ethanol: F(1,21) = 4.65, p < 0.05; Ethanol * Sex: F(1,21) = 0.05, n.s.). Interestingly, unlike with PACAP, no sex differences in CGRP levels could be observed in this region (Sex: F(1,21) = 0.20, n.s.). Figure 3D shows the data after pooling the two sexes; IA2BC overall caused a 19.2% increase in CGRP levels.

Inhibition of afferent PACAP projections to the BNST reduced heavy ethanol drinking in mice

As shown in the scheme in Figure 4A, a group of Pacap-ires-Cre mice were infused with a Cre-dependent retrograde virus expressing an hM4Di inhibitory DREADD expressing the fluorophore mCherry in the BNST. Extended Data Figure 4-1 shows the viral injection sites in the BNST; 7 of the 20 mice were removed because of absent or inaccurate injection placement (n = 13). As expected, mCherry was detected upstream in the LPB, as shown in Figure 4B. Importantly, as assessed with fluorescence in situ hybridization, the Cre dependency of the virus was verified as the expression of mCherry was restricted to PACAP-expressing cells. Indeed, mCherry was colocalized with PACAP (Adcyap1 gene, >95%) but not with tachykinin (Tac1 gene), another neuropeptide widely expressed in LPB, as shown in Figure 4C–G. The totality of PACAP-expressing neurons expressed mCherry only partially, consistent with the Cre line being heterozygous for Cre and with the spatial limitations of the viral spread. In addition, some neurons appeared to express both Adcyap1 and Tac1, in line with previous literature.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

A, Scheme and timeline of the chemogenetic experiment. B, Representative picture of mCherry fluorescence in the LPB. Scale bar, 100 μm. C–H, Verification (by in situ hybridization) of the selectivity of the retrograde AAV [AAVrg-hSyn-DIO-hM4D(Gi)-mCherry] for Adcyap1, and not Tac1, neurons in the LPB. Filled arrows indicate representative mCherry-expressing cells (where coexpression with Adcyap1 is visible); empty arrows indicate representative Tac1 (where absence of mCherry is visible). Extended Data Figure 4-1 shows the location of the AAVrg-hSyn-DIO-hM4D-mCherry infusions in the BNST.

Figure 4-1

A, Illustrations of coronal rat brain slices; numbers represent the distance from bregma (mm). Symbols represent the injection sites of the AAVrg-hSyn-DIO-hM4D-mCherry in the BNST (each dot is the location of one injection, each star the location of 2 or more injections). Download Figure 4-1, TIF file.

In AAVrg-hSyn-DIO-hM4D(Gi)-mCherry-infused mice exposed to chronic, intermittent ethanol access, administration of the selective DREADD ligand CNO (0–3 mg/kg, i.p.) dose-dependently reduced the incremental ethanol intake at both the 2 and 6 h time points, in both sexes (Dose: F(2,22) = 11.01, p < 0.001; Dose * Time: F(2,22) = 0.83, n.s.; Dose * Sex: F(2,22) = 1.58, n.s.). Post hoc analyses revealed that, at the 2 h time point, both doses of CNO (1 and 3 mg/kg) significantly reduced ethanol intake (−16.6% and −41.8%, respectively) as shown in Figure 5A (male and female data pooled); at the 6 h time point, only the 3 mg/kg dose significantly decreased intake (−31.8%). The effect of CNO persisted when looking at the cumulative 24 h ethanol intake (Dose: F(2,24) = 4.04, p < 0.05), with the highest dose causing an overall 16.6% reduction (Fig. 5B). However, in line with the reported CNO half-life, no effect of CNO could be observed on the incremental 6–24 h ethanol intake (Dose: F(2,24) = 0.05, n.s.).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

A–F, The effect of inhibition of PACAP neurons afferent to the BNST on ethanol intake (A, B), water intake (C, D), and ethanol preference (E, F). Administration of CNO (0–3 mg/kg, i.p.) dose-dependently reduced 2, 6, and 24 h ethanol intake in AAVrg-hSyn-DIO-hM4D(Gi)-mCherry BNST-infused mice, while it did not affect water intake. CNO also reduced 6 h ethanol preference. Data represent the mean ± SEM (n = 13 mice). *p < 0.05, **p < 0.01, ***p < 0.001; versus Vehicle.

Water intake was not significantly affected by the CNO treatment in either sex either at the 2 and 6 h time points (Dose: F(2,22) = 0.60, n.s.; Dose * Time: F(2,22) = 0.31, n.s.; Dose * Sex: F(2,22) = 1.19, n.s.) or at the 24 h time point (Dose: F(2,24) = 0.44, n.s.), as shown in Figure 5, C and D.

Preference for the ethanol solution showed a very strong trend to be affected by CNO treatment (Dose: F(2,22) = 2.40, p = 0.11; Dose * Time * Sex: F(2,22) = 3.44, p = 0.050), with a significant effect observed at the 6 h time point by the 3 mg/kg dose, as revealed by post hoc analysis (−20.5%), as shown in Figure 5E. No significant effect on ethanol preference persisted at 24 h (Fig. 5F).

Finally, food intake was not significantly affected by the CNO treatment in either sex at either the 2 and 6 h time points (Dose: F(2,22) = 1.00, n.s.; Dose * Time: F(2,22) = 0.02, n.s.; Dose * Sex: F(2,22) = 1.11, n.s.) or at the 24 h time point (Dose: F(2,24) = 0.07, n.s.; data not shown).

Discussion

The main findings of this series of studies were as follows: (1) chronic, intermittent ethanol drinking increases PACAP levels in the BNST, but not the CeA, of mice; (2) chronic, intermittent ethanol drinking does not affect the number of PAC1R-expressing cells in the BNST; (3) chronic, intermittent ethanol drinking also increases CGRP levels in the BNST; and (4) inhibition of afferent PACAP projections to the BNST is sufficient to reduce heavy ethanol drinking in mice.

Our immunohistochemistry data revealed an increased expression of PACAP-positive fibers specifically within the BSTld of mice exposed to 7 weeks of chronic, intermittent ethanol drinking, compared with control, water-drinking mice (+33.5%). This increase was observed 24 h after the end of the last drinking session, hence during acute withdrawal, when alcohol was no longer onboard. Our results in this mouse model of heavy alcohol drinking are consistent with previous studies that have shown increased PACAP expression in the BSTld in rats following chronic passive exposure to ethanol vapors (Ferragud et al., 2021), following chronic cocaine administration (Miles et al., 2018), and also following chronic variable stress (Hammack et al., 2009), suggesting that PACAP is recruited specifically in the BNST following chronic exposure to both stressors or drug and alcohol exposure. PACAP immunoreactivity in the BSTld, as well as the CeA (CeC and CeL subdivisions), appears as fibers, consistently with previous results from our and other laboratories and strengthening the notion that PACAP is not locally produced, but rather that these fibers are afferent projections from other brain areas (Piggins et al., 1996; Hannibal, 2002; Missig et al., 2014; Seiglie et al., 2019). Interestingly, in our mouse IA2BC model, PACAP levels were not significantly altered in the CeA, a brain region also part of the extended amygdala, which receives similar afferent projections, suggesting a selective effect in the BNST, in line with our previous finding in the rat dependence model (Ferragud et al., 2021). Notably, the number of PAC1R-positive cells, as assessed by immunohistochemistry, did not differ in the BSTld of ethanol drinking mice compared with controls; future studies incorporating different stages of ethanol exposure and withdrawal could, however, provide more comprehensive insights into the potential impact of chronic ethanol exposure on the expression of PAC1R-positive cells.

We also observed a significant increase in the levels of the neuropeptide CGRP in the BSTld of ethanol drinking mice, compared with controls (+19.2%). CGRP is a 37 aa peptide whose immunoreactivity displays considerable overlap with PACAP in the BNST, both being particularly abundant in fibers of the BSTld (Dobolyi et al., 2005; Hammack et al., 2009; Sink et al., 2011). It was shown that the majority of PACAP-expressing fibers in this region appears to coexpress CGRP (Missig et al., 2014), suggesting that these two neuropeptides may be coreleased from the same neurons, which likely originate in the LPB (Missig et al., 2014; Zhang et al., 2021; Jiang et al., 2023; Seiglie et al., 2023). CGRP also shares similarities with PACAP in terms of functions; CGRP has been shown to play an important role in the regulation of stress and anxiety-like behaviors, physical and emotional pain responses, migraine, and taste aversion (Kocorowski and Helmstetter, 2001; Campos et al., 2018; Chen et al., 2018). Despite the similarities, however, some recent studies in the context of migraine have suggested that the two peptides may act by independent mechanisms, possibly by distinct intracellular signaling pathways (Ernstsen et al., 2022; Kuburas and Russo, 2023). Interestingly, while an anxiogenic-like and pronociceptive role of CGRP in the CeA has been described (Han et al., 2005, 2010), much less is known about the function of CGRP in the BNST, warranting the need for further studies. The role of CGRP in alcohol addiction is still unclear. Alcohol directly evokes the release of CGRP in the trigeminal ganglia (Nicoletti et al., 2008). Early studies have also found lower basal CGRP levels in multiple brain regions of Indiana P alcohol-preferring rats, at the same time as increased levels during protracted withdrawal after ethanol vapor administration (Hwang et al., 1995; Ehlers et al., 1999). More recently, intermittent alcohol drinking during adolescence was shown to increase CGRP levels in the brainstem of rats (Tringali et al., 2023). In addition, in line with our current findings, continuous access to alcohol drinking was shown to increase CGRP levels in the BNST of Sardinian alcohol-preferring rats (Rossetti et al., 2019). The finding of increased levels of CGRP after heavy alcohol drinking in the BNST of C57BL/6 mice is, therefore, an interesting one, and the potential functional relevance of this change for alcohol drinking and associated negative states warrants further investigation.

The use of an AAV produced with a retrograde serotype permits retrograde access to projection neurons. Specifically, to assess the significance of the increased PACAP levels in the BNST following intermittent alcohol drinking, we used a retrograde chemogenetic approach in Pacap-ires-Cre mice to Cre-dependently inhibit PACAP neurons that project to the BNST and then measured ethanol intake. Our results show that the chemogenetic inhibition of PACAP afferents to the BNST is sufficient to reduce ethanol drinking behavior. The effect was more marked at the 2 h time point, with both doses of CNO producing a significant reduction in ethanol intake (−16.6% and −41.8%, compared with vehicle treatment, respectively), consistent with the short half-life of the DREADD ligand CNO. The effect of the high dose of CNO, however, was still evident at the 6 h (−31.8%) and 24 h (−16.6%) time points, and ethanol preference was also significantly reduced at the 24 h time point. Water intake was not affected by the PACAP pathways inhibition, ruling out the alternative explanation that the manipulation may have induced malaise.

The present data suggest that neuronal pathways that express PACAP and project to the BNST contribute to the high levels of alcohol drinking seen in this mouse model. Stressors have been shown to increase PACAP levels within the BNST and intra-BNST PAC1R antagonism attenuates the response to stress as well as stress-induced reinstatement of cocaine-seeking behavior (Roman et al., 2014; Lezak et al., 2014b; Miles et al., 2018; Seiglie et al., 2019, 2022). Recently, it has been shown that antagonism of PAC1R within the BNST is able to reduce dependence-induced excessive drinking as well as heightened anxiety-like behavior in rats exposed to alcohol vapors (Ferragud et al., 2021); hence, also considering the immunohistochemical data showing increased PACAP levels in the BNST in both models, we can conclude that chronic, intermittent exposure to ethanol consistently recruits the PACAP system of the BNST. Therefore, although chemogenetic approaches manipulate entire neuronal populations rather than individual neurotransmitter systems, we hypothesize that the increased PACAP release onto BNST neurons acts via PAC1R to mediate heavy alcohol drinking.

These data strongly suggest that the PACAP population mediating alcohol-related behaviors and alcohol drinking originates in brain regions sending PACAP projections to the BNST, consistent with the lack of reported PACAP mRNA in the mouse BNST. The type of approach we used here does not differentiate among specific inputs to the BNST, and, therefore, experiments directly manipulating a single PACAPergic pathway to the BNST will be necessary to ascertain the exact origin. Although multiple brain regions that project to the BNST are known to contain PACAP neurons (e.g., paraventricular nucleus of the hypothalamus, paraventricular nucleus of the thalamus, medial prefrontal cortex, dorsal vagal complex, and LPB; Weller and Smith, 1982; Légrádi et al., 1994; Kozicz et al., 1997; Missig et al., 2014; Missig et al., 2017; Kirry et al., 2018), recent studies have suggested that the majority of PACAP terminals found in both the BNST and the CeA originates in the LPB, which is recognized as a critical source of the peptide in these regions (Missig et al., 2014, 2017; Zhang et al., 2021; Jiang et al., 2023). In line with these observations, we confirmed the presence of mCherry in the LPB of the mice injected with the retrograde AAV in the BNST. In addition, we verified that our retrograde AAV only infected PACAP-expressing neurons and not another neuronal population also present in the LPB, Tac1-expressing neurons. The LPB, and in particular the external subnucleus, is indeed densely populated with PACAP-positive neurons that coexpress the glutamatergic marker VGluT2 and that largely overlap with CGRP-expressing neurons; these PACAP neurons mainly innervate the extended amygdala (Missig et al., 2014, 2017; Zhang et al., 2021; Pauli et al., 2022; Jiang et al., 2023). Interestingly, the chemogenetic activation of either the LPB-BNST or the LPB-CeA PACAP projection enhances anxiety-like behavior (Boucher et al., 2022; Seiglie et al., 2023), while the effects of the direct stimulation of these pathways on alcohol-related behaviors has not yet been investigated. Since axonal transport does not allow the visualization of clear peptide immunostaining in cell bodies, future studies will assess the effects of alcohol drinking on PACAP and CGRP mRNA expression in LPB, also assessing their coexpression.

Our experiments included both male and female mice. The BNST, in general, has a plethora of sexually dimorphic behavioral effects (Lebow and Chen, 2016). In the context of the PACAP/PAC1R system, sex differences have been reported in the context of stress-related behaviors and of nicotine effects (Ressler et al., 2011; King et al., 2017; Nega et al., 2020; Clancy et al., 2023; Slabe et al., 2023), and basal levels of PACAP were shown to be higher in specific brain regions of female animals (Curtis et al., 2023). On the other hand, other studies have reported no sex differences in the role of the PACAP/PAC1R system (Rajbhandari et al., 2021). In this study, we observed higher levels of PACAP in the BNST in female mice, which strengthens the notion of a sexual dimorphism of the PACAP system also in this brain area and perhaps suggests that higher endogenous levels of PACAP may predispose females to drink more alcohol. However, the effect of chronic alcohol drinking on PACAP levels did not differ in the two sexes. Similarly, no sex differences were observed in the effects of alcohol on CGRP and PAC1R levels, and no sex differences were found in alcohol drinking following the manipulation of the PACAP pathways to the BNST, suggesting a lack of sex differences in the action of chronic alcohol on these pathways. Future studies may address the role of sex hormones in the role of PACAP in alcohol-drinking behavior.

This study has a few limitations. The effects of the inhibition of PACAP afferents to the BNST were not assessed on the intake of an alternative reinforcer, as for example sucrose, which is useful to determine the selectivity of the effects for alcohol. In addition, the chemogenetic study did not include a control, non-DREADD virus to rule out a potential intrinsic effect of the DREADD ligand CNO on alcohol drinking; however, several studies have now shown that these doses of CNO do not affect ethanol intake per se in rodents (den Hartog et al., 2016; Kreifeldt et al., 2022; Suresh Nair et al., 2022; Griffin et al., 2023; Khan et al., 2023; Zamudio et al., 2023).

Together, these data suggest that BNST PACAP, possibly originating from cell bodies in the LPB, has a central role in driving heavy alcohol drinking in mice. This system may, therefore, represent a promising target for the development of novel treatments for AUD.

Footnotes

  • The authors declare no competing financial interests.

  • This publication was made possible thanks to Grants AA-026051 (to P.C.), AA-025038 (to V.S.), and AA-024439 (to V.S.) from the National Institute on Alcohol and Alcoholism; the Boston University Undergraduate Research Opportunities Program; the Boston University Micro and Nano Imaging Facility; and the Office of the Director of the National Institutes of Health (Grant S10-OD-024993). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

  • Acknowledgement: We thank Jake Rauh, Jacy Marquez, and Teresa Le for their precious technical help.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Agarwal A, Halvorson LM, Legradi G (2005) Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res 138:45–57. https://doi.org/10.1016/j.molbrainres.2005.03.016 pmid:15882914
    OpenUrlCrossRefPubMed
  2. ↵
    Avery SN, Clauss JA, Blackford JU (2016) The human BNST: functional role in anxiety and addiction. Neuropsychopharmacology 41:126–141. https://doi.org/10.1038/npp.2015.185 pmid:26105138
    OpenUrlCrossRefPubMed
  3. ↵
    Boucher MN, Aktar M, Braas KM, May V, Hammack SE (2022) Activation of lateral parabrachial nucleus (LPBn) PACAP-expressing projection neurons to the bed nucleus of the stria terminalis (BNST) enhances anxiety-like behavior. J Mol Neurosci 72:451–458. https://doi.org/10.1007/s12031-021-01946-z pmid:34811712
    OpenUrlPubMed
  4. ↵
    Breese GR, Sinha R, Heilig M (2011) Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther 129:149–171. https://doi.org/10.1016/j.pharmthera.2010.09.007 pmid:20951730
    OpenUrlCrossRefPubMed
  5. ↵
    Campos CA, Bowen AJ, Roman CW, Palmiter RD (2018) Encoding of danger by parabrachial CGRP neurons. Nature 555:617–622. https://doi.org/10.1038/nature25511 pmid:29562230
    OpenUrlCrossRefPubMed
  6. ↵
    Chen JY, Campos CA, Jarvie BC, Palmiter RD (2018) Parabrachial CGRP neurons establish and sustain aversive taste memories. Neuron 100:891–899.e5. https://doi.org/10.1016/j.neuron.2018.09.032 pmid:30344042
    OpenUrlCrossRefPubMed
  7. ↵
    Clancy KJ, Devignes Q, Kumar P, May V, Hammack SE, Akman E, Casteen EJ, Pernia CD, Jobson SA, Lewis MW, Daskalakis NP, Carlezon WA Jr., Ressler KJ, Rauch SL, Rosso IM (2023) Circulating PACAP levels are associated with increased amygdala-default mode network resting-state connectivity in posttraumatic stress disorder. Neuropsychopharmacology 48:1245–1254. https://doi.org/10.1038/s41386-023-01593-5 pmid:37161077
    OpenUrlPubMed
  8. ↵
    Csati A, Tajti J, Kuris A, Tuka B, Edvinsson L, Warfvinge K (2012) Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion. Neuroscience 202:158–168. https://doi.org/10.1016/j.neuroscience.2011.10.055 pmid:22108610
    OpenUrlPubMed
  9. ↵
    Curtis GR, Gargiulo AT, Carpenter BA, Pirino BE, Hawks A, Coleman SA, Syed NA, Gupta A, Barson JR (2023) Sex-related differences in endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) in the thalamic paraventricular nucleus: implications for addiction neuroscience. Addict Neurosci 5:100058. https://doi.org/10.1016/j.addicn.2022.100058
    OpenUrl
  10. ↵
    Das M, Vihlen CS, Legradi G (2007) Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 500:761–776. https://doi.org/10.1002/cne.21212 pmid:17154257
    OpenUrlCrossRefPubMed
  11. ↵
    den Hartog C, Zamudio-Bulcock P, Nimitvilai S, Gilstrap M, Eaton B, Fedarovich H, Motts A, Woodward JJ (2016) Inactivation of the lateral orbitofrontal cortex increases drinking in ethanol-dependent but not non-dependent mice. Neuropharmacology 107:451–459. https://doi.org/10.1016/j.neuropharm.2016.03.031 pmid:27016020
    OpenUrlCrossRefPubMed
  12. ↵
    Dobolyi A, Irwin S, Makara G, Usdin TB, Palkovits M (2005) Calcitonin gene-related peptide-containing pathways in the rat forebrain. J Comp Neurol 489:92–119. https://doi.org/10.1002/cne.20618 pmid:15977170
    OpenUrlCrossRefPubMed
  13. ↵
    Dore R, Iemolo A, Smith KL, Wang X, Cottone P, Sabino V (2013) CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology 38:2160–2169. https://doi.org/10.1038/npp.2013.113 pmid:23657440
    OpenUrlCrossRefPubMed
  14. ↵
    Dragan WL, Czerski PM, Dragan M (2017) PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women. Neuropsychiatr Dis Treat 13:1483–1489. https://doi.org/10.2147/NDT.S137331 pmid:28652748
    OpenUrlPubMed
  15. ↵
    Ehlers CL, Somes C, Li TK, Lumeng L, Hwang BH, Jimenez P, Mathé AA (1999) Calcitonin gene-related peptide (CGRP) levels and alcohol. Int J Neuropsychopharmacol 2:173–179. https://doi.org/10.1017/S1461145799001558 pmid:11281986
    OpenUrlCrossRefPubMed
  16. ↵
    Ernstsen C, Christensen SL, Rasmussen RH, Nielsen BS, Jansen-Olesen I, Olesen J, Kristensen DM (2022) The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target? Brain 145:2450–2460. https://doi.org/10.1093/brain/awac040 pmid:35136961
    OpenUrlPubMed
  17. ↵
    Feany MB, Quinn WG (1995) A neuropeptide gene defined by the Drosophila memory mutant amnesiac. Science 268:869–873. https://doi.org/10.1126/science.7754370 pmid:7754370
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Ferragud A, Velázquez-Sánchez C, Abdullatif AA, Sabino V, Cottone P (2020) Withdrawal from extended, intermittent access to a highly palatable diet impairs hippocampal memory function and neurogenesis: effects of memantine. Nutrients 12:1520. https://doi.org/10.3390/nu12051520
    OpenUrlCrossRef
  19. ↵
    Ferragud A, Velazquez-Sanchez C, Minnig MA, Sabino V, Cottone P (2021) Pituitary adenylate cyclase-activating polypeptide (PACAP) modulates dependence-induced alcohol drinking and anxiety-like behavior in male rats. Neuropsychopharmacology 46:509–518. https://doi.org/10.1038/s41386-020-00904-4 pmid:33191400
    OpenUrlCrossRefPubMed
  20. ↵
    Flanigan ME, Hon OJ, D'Ambrosio S, Boyt KM, Hassanein L, Castle M, Haun HL, Pina MM, Kash TL (2023) Subcortical serotonin 5HT(2c) receptor-containing neurons sex-specifically regulate binge-like alcohol consumption, social, and arousal behaviors in mice. Nat Commun 14:1800. https://doi.org/10.1038/s41467-023-36808-2 pmid:37002196
    OpenUrlPubMed
  21. ↵
    Gargiulo AT, Curtis GR, Barson JR (2020) Pleiotropic pituitary adenylate cyclase-activating polypeptide (PACAP): novel insights into the role of PACAP in eating and drug intake. Brain Res 1729:146626. https://doi.org/10.1016/j.brainres.2019.146626 pmid:31883848
    OpenUrlPubMed
  22. ↵
    Gaszner B, Kormos V, Kozicz T, Hashimoto H, Reglodi D, Helyes Z (2012) The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus. Neuroscience 202:283–299. https://doi.org/10.1016/j.neuroscience.2011.11.046 pmid:22178610
    OpenUrlCrossRefPubMed
  23. ↵
    Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR (1993) Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol 136:159–166. https://doi.org/10.1677/joe.0.1360159 pmid:8094091
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Griffin WC, Lopez MF, Woodward JJ, Becker HC (2023) Alcohol dependence and the ventral hippocampal influence on alcohol drinking in male mice. Alcohol 106:44–54. https://doi.org/10.1016/j.alcohol.2022.10.004 pmid:36328184
    OpenUrlPubMed
  25. ↵
    Hammack SE, May V (2015) Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies. Biol Psychiatry 78:167–177. https://doi.org/10.1016/j.biopsych.2014.12.003 pmid:25636177
    OpenUrlCrossRefPubMed
  26. ↵
    Hammack SE, Cheung J, Rhodes KM, Schutz KC, Falls WA, Braas KM, May V (2009) Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 34:833–843. https://doi.org/10.1016/j.psyneuen.2008.12.013 pmid:19181454
    OpenUrlCrossRefPubMed
  27. ↵
    Han JS, Li W, Neugebauer V (2005) Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci 25:10717–10728. https://doi.org/10.1523/JNEUROSCI.4112-05.2005 pmid:16291945
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Han JS, Adwanikar H, Li Z, Ji G, Neugebauer V (2010) Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain 6:10. https://doi.org/10.1186/1744-8069-6-10 pmid:20144185
    OpenUrlCrossRefPubMed
  29. ↵
    Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453:389–417. https://doi.org/10.1002/cne.10418 pmid:12389210
    OpenUrlCrossRefPubMed
  30. ↵
    Hannibal J, Mikkelsen JD, Fahrenkrug J, Larsen PJ (1995) Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. Endocrinology 136:4116–4124. https://doi.org/10.1210/endo.136.9.7649120 pmid:7649120
    OpenUrlCrossRefPubMed
  31. ↵
    Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J (2002) The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 22:RC191. https://doi.org/10.1523/JNEUROSCI.22-01-j0002.2002 pmid:11756521
    OpenUrlFREE Full Text
  32. ↵
    Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, Miyazaki J, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, Suetake S, Baba A (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 98:13355–13360. https://doi.org/10.1073/pnas.231094498 pmid:11687615
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA (2011) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res 35:1938–1947. https://doi.org/10.1111/j.1530-0277.2011.01545.x pmid:21631540
    OpenUrlCrossRefPubMed
  34. ↵
    Hwang BH, Kunkler PE, Lumeng L, Li TK (1995) Calcitonin gene-related peptide (CGRP) content and CGRP receptor binding sites in discrete forebrain regions of alcohol-preferring vs. -nonpreferring rats, and high alcohol-drinking vs. low alcohol-drinking rats. Brain Res 690:249–253. https://doi.org/10.1016/0006-8993(95)00636-5 pmid:8535845
    OpenUrlPubMed
  35. ↵
    Iemolo A, Seiglie M, Blasio A, Cottone P, Sabino V (2016) Pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nucleus of the amygdala induces anxiety via melanocortin receptors. Psychopharmacology (Berl) 233:3269–3277. https://doi.org/10.1007/s00213-016-4366-y pmid:27376948
    OpenUrlCrossRefPubMed
  36. ↵
    Jiang SZ, Zhang HY, Eiden LE (2023) PACAP controls endocrine and behavioral stress responses via separate brain circuits. Biol Psychiatry Glob Open Sci 3:673–685. https://doi.org/10.1016/j.bpsgos.2023.04.001 pmid:37881538
    OpenUrlPubMed
  37. ↵
    Kash TL, Baucum AJ 2nd., Conrad KL, Colbran RJ, Winder DG (2009) Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Neuropsychopharmacology 34:2420–2429. https://doi.org/10.1038/npp.2009.69 pmid:19553918
    OpenUrlCrossRefPubMed
  38. ↵
    Kash TL, Pleil KE, Marcinkiewcz CA, Lowery-Gionta EG, Crowley N, Mazzone C, Sugam J, Hardaway JA, McElligott ZA (2015) Neuropeptide regulation of signaling and behavior in the BNST. Mol Cells 38:1–13. https://doi.org/10.14348/molcells.2015.2261 pmid:25475545
    OpenUrlCrossRefPubMed
  39. ↵
    Khan KM, Bierlein-De La Rosa G, Biggerstaff N, Pushpavathi Selvakumar G, Wang R, Mason S, Dailey ME, Marcinkiewcz CA (2023) Adolescent ethanol drinking promotes hyperalgesia, neuroinflammation and serotonergic deficits in mice that persist into adulthood. Brain Behav Immun 107:419–431. https://doi.org/10.1016/j.bbi.2022.07.160 pmid:35907582
    OpenUrlPubMed
  40. ↵
    Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS, Lo M, Pak S, Mattis J, Lim BK, Malenka RC, Warden MR, Neve R, Tye KM, Deisseroth K (2013) Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496:219–223. https://doi.org/10.1038/nature12018 pmid:23515158
    OpenUrlCrossRefPubMed
  41. ↵
    King SB, Toufexis DJ, Hammack SE (2017) Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones. Stress 20:465–475. https://doi.org/10.1080/10253890.2017.1336535 pmid:28610473
    OpenUrlCrossRefPubMed
  42. ↵
    Kirry AJ, Herbst MR, Poirier SE, Maskeri MM, Rothwell AC, Twining RC, Gilmartin MR (2018) Pituitary adenylate cyclase-activating polypeptide (PACAP) signaling in the prefrontal cortex modulates cued fear learning, but not spatial working memory, in female rats. Neuropharmacology 133:145–154. https://doi.org/10.1016/j.neuropharm.2018.01.010 pmid:29353055
    OpenUrlCrossRefPubMed
  43. ↵
    Kocho-Schellenberg M, Lezak KR, Harris OM, Roelke E, Gick N, Choi I, Edwards S, Wasserman E, Toufexis DJ, Braas KM, May V, Hammack SE (2014) PACAP in the BNST produces anorexia and weight loss in male and female rats. Neuropsychopharmacology 39:1614–1623. https://doi.org/10.1038/npp.2014.8 pmid:24434744
    OpenUrlCrossRefPubMed
  44. ↵
    Kocorowski LH, Helmstetter FJ (2001) Calcitonin gene-related peptide released within the amygdala is involved in Pavlovian auditory fear conditioning. Neurobiol Learn Mem 75:149–163. https://doi.org/10.1006/nlme.2000.3963 pmid:11222057
    OpenUrlCrossRefPubMed
  45. ↵
    Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232–243. https://doi.org/10.1097/01.ALC.0000057122.36127.C2 pmid:12605072
    OpenUrlCrossRefPubMed
  46. ↵
    Koob GF (2009) Brain stress systems in the amygdala and addiction. Brain Res 1293:61–75. https://doi.org/10.1016/j.brainres.2009.03.038 pmid:19332030
    OpenUrlCrossRefPubMed
  47. ↵
    Koob GF (2021) Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development. Pharmacol Rev 73:163–201. https://doi.org/10.1124/pharmrev.120.000083 pmid:33318153
    OpenUrlCrossRefPubMed
  48. ↵
    Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760–773. https://doi.org/10.1016/S2215-0366(16)00104-8 pmid:27475769
    OpenUrlCrossRefPubMed
  49. ↵
    Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lönnqvist J, Partonen T (2010) Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol 45:303–311. https://doi.org/10.1093/alcalc/agq035 pmid:20554694
    OpenUrlCrossRefPubMed
  50. ↵
    Kozicz T, Vigh S, Arimura A (1997) Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 767:109–119. https://doi.org/10.1016/s0006-8993(97)00737-3 pmid:9365022
    OpenUrlCrossRefPubMed
  51. ↵
    Krashes MJ, Shah BP, Madara JC, Olson DP, Strochlic DE, Garfield AS, Vong L, Pei H, Watabe-Uchida M, Uchida N, Liberles SD, Lowell BB (2014) An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 507:238–242. https://doi.org/10.1038/nature12956 pmid:24487620
    OpenUrlCrossRefPubMed
  52. ↵
    Kreifeldt M, Herman MA, Sidhu H, Okhuarobo A, Macedo GC, Shahryari R, Gandhi PJ, Roberto M, Contet C (2022) Central amygdala corticotropin-releasing factor neurons promote hyponeophagia but do not control alcohol drinking in mice. Mol Psychiatry 27:2502–2513. https://doi.org/10.1038/s41380-022-01496-9 pmid:35264727
    OpenUrlPubMed
  53. ↵
    Kuburas A, Russo AF (2023) Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain 24:34. https://doi.org/10.1186/s10194-023-01569-2 pmid:37009867
    OpenUrlPubMed
  54. ↵
    Lebow MA, Chen A (2016) Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry 21:450–463. https://doi.org/10.1038/mp.2016.1 pmid:26878891
    OpenUrlCrossRefPubMed
  55. ↵
    Légrádi G, Shioda S, Arimura A (1994) Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata. Neurosci Lett 176:193–196. https://doi.org/10.1016/0304-3940(94)90080-9 pmid:7830945
    OpenUrlCrossRefPubMed
  56. ↵
    Lehmann ML, Mustafa T, Eiden AM, Herkenham M, Eiden LE (2013) PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress. Psychoneuroendocrinology 38:702–715. https://doi.org/10.1016/j.psyneuen.2012.09.006 pmid:23062748
    OpenUrlCrossRefPubMed
  57. ↵
    Lezak KR, Roelke E, Harris OM, Choi I, Edwards S, Gick N, Cocchiaro G, Missig G, Roman CW, Braas KM, Toufexis DJ, May V, Hammack SE (2014a) Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats. Psychoneuroendocrinology 45:11–20. https://doi.org/10.1016/j.psyneuen.2014.03.007 pmid:24845172
    OpenUrlCrossRefPubMed
  58. ↵
    Lezak KR, Roman CW, Braas KM, Schutz KC, Falls WA, Schulkin J, May V, Hammack SE (2014b) Regulation of bed nucleus of the stria terminalis PACAP expression by stress and corticosterone. J Mol Neurosci 54:477–484. https://doi.org/10.1007/s12031-014-0269-8 pmid:24614974
    OpenUrlCrossRefPubMed
  59. ↵
    Liu Q, Wong-Riley MTT (2019) Pituitary adenylate cyclase-activating polypeptide: postnatal development in multiple brain stem respiratory-related nuclei in the rat. Respir Physiol Neurobiol 259:149–155. https://doi.org/10.1016/j.resp.2018.10.005 pmid:30359769
    OpenUrlPubMed
  60. ↵
    Marcinkiewcz CA, Dorrier CE, Lopez AJ, Kash TL (2015) Ethanol induced adaptations in 5-HT2c receptor signaling in the bed nucleus of the stria terminalis: implications for anxiety during ethanol withdrawal. Neuropharmacology 89:157–167. https://doi.org/10.1016/j.neuropharm.2014.09.003 pmid:25229718
    OpenUrlCrossRefPubMed
  61. ↵
    Marcinkiewcz CA, Mazzone CM, D'Agostino G, Halladay LR, Hardaway JA, DiBerto JF, Navarro M, Burnham N, Cristiano C, Dorrier CE, Tipton GJ, Ramakrishnan C, Kozicz T, Deisseroth K, Thiele TE, McElligott ZA, Holmes A, Heisler LK, Kash TL (2016) Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature 537:97–101. https://doi.org/10.1038/nature19318 pmid:27556938
    OpenUrlCrossRefPubMed
  62. ↵
    Mason BJ, Heyser CJ (2021) Alcohol use disorder: the role of medication in recovery. Alcohol Res 41:07.
    OpenUrl
  63. ↵
    Matsumoto M, Nakamachi T, Watanabe J, Sugiyama K, Ohtaki H, Murai N, Sasaki S, Xu Z, Hashimoto H, Seki T, Miyazaki A, Shioda S (2016) Pituitary adenylate cyclase-activating polypeptide (PACAP) is involved in adult mouse hippocampal neurogenesis after stroke. J Mol Neurosci 59:270–279. https://doi.org/10.1007/s12031-016-0731-x pmid:26910758
    OpenUrlPubMed
  64. ↵
    Meloni EG, Kaye KT, Venkataraman A, Carlezon WA Jr. (2019) PACAP increases Arc/Arg 3.1 expression within the extended amygdala after fear conditioning in rats. Neurobiol Learn Mem 157:24–34. https://doi.org/10.1016/j.nlm.2018.11.011 pmid:30458282
    OpenUrlCrossRefPubMed
  65. ↵
    Miles OW, Thrailkill EA, Linden AK, May V, Bouton ME, Hammack SE (2018) Pituitary adenylate cyclase-activating peptide in the bed nucleus of the stria terminalis mediates stress-induced reinstatement of cocaine seeking in rats. Neuropsychopharmacology 43:978–986. https://doi.org/10.1038/npp.2017.135 pmid:28656976
    OpenUrlPubMed
  66. ↵
    Minnig MA, Park T, Echeveste Sanchez M, Cottone P, Sabino V (2021) Viral-mediated knockdown of nucleus accumbens shell PAC1 receptor promotes excessive alcohol drinking in alcohol-preferring rats. Front Behav Neurosci 15:787362. https://doi.org/10.3389/fnbeh.2021.787362 pmid:34924973
    OpenUrlCrossRefPubMed
  67. ↵
    Minnig MA, Blasio A, Ferragud A, Sami YN, Erhard EE, Clark RH, DiLeo A, Giuliano C, Everitt BJ, Cottone P, Sabino V (2022) Pituitary adenylate cyclase-activating polypeptide type 1 receptor within the nucleus accumbens core mediates excessive alcohol drinking in alcohol-preferring rats. Neuropharmacology 212:109063. https://doi.org/10.1016/j.neuropharm.2022.109063 pmid:35460713
    OpenUrlCrossRefPubMed
  68. ↵
    Missig G, Roman CW, Vizzard MA, Braas KM, Hammack SE, May V (2014) Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: implication for the sensory and behavioral effects of pain. Neuropharmacology 86:38–48. https://doi.org/10.1016/j.neuropharm.2014.06.022 pmid:24998751
    OpenUrlCrossRefPubMed
  69. ↵
    Missig G, Mei L, Vizzard MA, Braas KM, Waschek JA, Ressler KJ, Hammack SE, May V (2017) Parabrachial pituitary adenylate cyclase-activating polypeptide activation of amygdala endosomal extracellular signal-regulated kinase signaling regulates the emotional component of pain. Biol Psychiatry 81:671–682. https://doi.org/10.1016/j.biopsych.2016.08.025 pmid:28057459
    OpenUrlCrossRefPubMed
  70. ↵
    Nakamura K, Nakamachi T, Endo K, Ito K, Machida T, Oka T, Hori M, Ishizaka K, Shioda S (2014) Distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) in the human testis and in testicular germ cell tumors. Andrologia 46:465–471. https://doi.org/10.1111/and.12102 pmid:23621806
    OpenUrlPubMed
  71. ↵
    Navarro M, Luhn KL, Kampov-Polevoy AB, Garbutt JC, Thiele TE (2019) Bupropion, alone and in combination with naltrexone, blunts binge-like ethanol drinking and intake following chronic intermittent access to ethanol in male C57BL/6J mice. Alcohol Clin Exp Res 43:783–790. https://doi.org/10.1111/acer.13992 pmid:30817015
    OpenUrlPubMed
  72. ↵
    Nega S, Marquez P, Hamid A, Ahmad SM, Lutfy K (2020) The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal. J Neurosci Res 98:1549–1560. https://doi.org/10.1002/jnr.24649 pmid:32476165
    OpenUrlPubMed
  73. ↵
    Newman EL, Albrechet-Souza L, Andrew PM, Auld JG, Burk KC, Hwa LS, Zhang EY, DeBold JF, Miczek KA (2018) Persistent escalation of alcohol consumption by mice exposed to brief episodes of social defeat stress: suppression by CRF-R1 antagonism. Psychopharmacology (Berl) 235:1807–1820. https://doi.org/10.1007/s00213-018-4905-9 pmid:29696309
    OpenUrlPubMed
  74. ↵
    Nicoletti P, Trevisani M, Manconi M, Gatti R, De Siena G, Zagli G, Benemei S, Capone JA, Geppetti P, Pini LA (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9–17. https://doi.org/10.1111/j.1468-2982.2007.01448.x pmid:17888011
    OpenUrlCrossRefPubMed
  75. ↵
    Norrholm SD, Das M, Légrádi G (2005) Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN). Regul Pept 128:33–41. https://doi.org/10.1016/j.regpep.2004.12.023 pmid:15721485
    OpenUrlCrossRefPubMed
  76. ↵
    Pati D, Marcinkiewcz CA, DiBerto JF, Cogan ES, McElligott ZA, Kash TL (2020) Chronic intermittent ethanol exposure dysregulates a GABAergic microcircuit in the bed nucleus of the stria terminalis. Neuropharmacology 168:107759. https://doi.org/10.1016/j.neuropharm.2019.107759 pmid:31494142
    OpenUrlPubMed
  77. ↵
    Pauli JL, Chen JY, Basiri ML, Park S, Carter ME, Sanz E, McKnight GS, Stuber GD, Palmiter RD (2022) Molecular and anatomical characterization of parabrachial neurons and their axonal projections. Elife 11:e81868. https://doi.org/10.7554/eLife.81868
    OpenUrl
  78. ↵
    Piggins HD, Stamp JA, Burns J, Rusak B, Semba K (1996) Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat. J Comp Neurol 376:278–294. https://doi.org/10.1002/(SICI)1096-9861(19961209)376:2<278::AID-CNE9>3.0.CO;2-0
    OpenUrlCrossRefPubMed
  79. ↵
    Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, Olson DP, Lowell BB, Grant KA, Thiele TE, Kash TL (2015) NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci 18:545–552. https://doi.org/10.1038/nn.3972 pmid:25751534
    OpenUrlCrossRefPubMed
  80. ↵
    Quadir SG, Rohl CD, Zeabi A, Moore CF, Cottone P, Sabino V (2020) Effect of different standard rodent diets on ethanol intake and associated allodynia in male mice. Alcohol 87:17–23. https://doi.org/10.1016/j.alcohol.2020.04.003 pmid:32330590
    OpenUrlPubMed
  81. ↵
    Quadir SG, Tanino SM, Rohl CD, Sahn JJ, Yao EJ, Cruz LDR, Cottone P, Martin SF, Sabino V (2021a) The Sigma-2 receptor/transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice. Neuropharmacology 184:108409. https://doi.org/10.1016/j.neuropharm.2020.108409 pmid:33221481
    OpenUrlPubMed
  82. ↵
    Quadir SG, Tanino SM, Sami YN, Minnig MA, Iyer MR, Rice KC, Cottone P, Sabino V (2021b) Antagonism of Sigma-1 receptor blocks heavy alcohol drinking and associated hyperalgesia in male mice. Alcohol Clin Exp Res 45:1398–1407. https://doi.org/10.1111/acer.14635 pmid:34060104
    OpenUrlPubMed
  83. ↵
    Rajbhandari AK, Octeau CJ, Gonzalez S, Pennington ZT, Mohamed F, Trott J, Chavez J, Ngyuen E, Keces N, Hong WZ, Neve RL, Waschek J, Khakh BS, Fanselow MS (2021) A basomedial amygdala to intercalated cells microcircuit expressing PACAP and its receptor PAC1 regulates contextual fear. J Neurosci 41:3446–3461. https://doi.org/10.1523/JNEUROSCI.2564-20.2021 pmid:33637560
    OpenUrlAbstract/FREE Full Text
  84. ↵
    Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V (2011) Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470:492–497. https://doi.org/10.1038/nature09856 pmid:21350482
    OpenUrlCrossRefPubMed
  85. ↵
    Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, Mahoney J, Pasic J, Weaver M, Wills CD, McIntyre J, Kidd J, Yager J, Hong SH (2018) The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry 175:86–90. https://doi.org/10.1176/appi.ajp.2017.1750101 pmid:29301420
    OpenUrlCrossRefPubMed
  86. ↵
    Roman CW, Lezak KR, Hartsock MJ, Falls WA, Braas KM, Howard AB, Hammack SE, May V (2014) PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress. Psychoneuroendocrinology 47:151–165. https://doi.org/10.1016/j.psyneuen.2014.05.014 pmid:25001965
    OpenUrlCrossRefPubMed
  87. ↵
    Ross RA, Leon S, Madara JC, Schafer D, Fergani C, Maguire CA, Verstegen AM, Brengle E, Kong D, Herbison AE, Kaiser UB, Lowell BB, Navarro VM (2018) PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse. Elife 7:e35960. https://doi.org/10.7554/eLife.35960
    OpenUrl
  88. ↵
    Rossetti I, Zambusi L, Maccioni P, Sau R, Provini L, Castelli MP, Gonciarz K, Colombo G, Morara S (2019) Predisposition to alcohol drinking and alcohol consumption alter expression of calcitonin gene-related peptide, neuropeptide Y, and microglia in bed nucleus of stria terminalis in a subnucleus-specific manner. Front Cell Neurosci 13:158. https://doi.org/10.3389/fncel.2019.00158 pmid:31114482
    OpenUrlPubMed
  89. ↵
    Sabino V, Kwak J, Rice KC, Cottone P (2013) Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res 37:635–643. https://doi.org/10.1111/acer.12008 pmid:23126554
    OpenUrlCrossRefPubMed
  90. ↵
    Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD (2015) 2010 National and state costs of excessive alcohol consumption. Am J Prev Med 49:e73–e79. https://doi.org/10.1016/j.amepre.2015.05.031 pmid:26477807
    OpenUrlCrossRefPubMed
  91. ↵
    Seiglie MP, Smith KL, Blasio A, Cottone P, Sabino V (2015) Pituitary adenylate cyclase-activating polypeptide induces a depressive-like phenotype in rats. Psychopharmacology (Berl) 232:3821–3831. https://doi.org/10.1007/s00213-015-4045-4 pmid:26264905
    OpenUrlCrossRefPubMed
  92. ↵
    Seiglie MP, Huang L, Cottone P, Sabino V (2019) Role of the PACAP system of the extended amygdala in the acoustic startle response in rats. Neuropharmacology 160:107761. https://doi.org/10.1016/j.neuropharm.2019.107761 pmid:31493466
    OpenUrlCrossRefPubMed
  93. ↵
    Seiglie MP, Lepeak L, Velázquez-Sanchez C, Ferragud A, Le T, Cottone P, Sabino V (2022) The pituitary adenylate cyclase-activating polypeptide (PACAP) system of the central amygdala mediates the detrimental effects of chronic social defeat stress in rats. eNeuro 9:ENEURO.0260-22.2022. https://doi.org/10.1523/ENEURO.0260-22.2022
    OpenUrl
  94. ↵
    Seiglie MP, Lepeak L, Miracle S, Cottone P, Sabino V (2023) Stimulation of lateral parabrachial (LPB) to central amygdala (CeA) pituitary adenylate cyclase-activating polypeptide (PACAP) neurons induces anxiety-like behavior and mechanical allodynia. Pharmacol Biochem Behav 230:173605. https://doi.org/10.1016/j.pbb.2023.173605 pmid:37499765
    OpenUrlPubMed
  95. ↵
    Sink KS, Walker DL, Yang Y, Davis M (2011) Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci 31:1802–1810. https://doi.org/10.1523/JNEUROSCI.5274-10.2011 pmid:21289190
    OpenUrlAbstract/FREE Full Text
  96. ↵
    Slabe Z, Pechler GA, van Heerikhuize J, Samuels BA, Živin M, Zorović M, Swaab DF (2023) Increased pituitary adenylate cyclase-activating polypeptide in the central bed nucleus of the stria terminalis in mood disorders in men. Neurobiol Dis 183:106191. https://doi.org/10.1016/j.nbd.2023.106191 pmid:37290577
    OpenUrlPubMed
  97. ↵
    Stamatakis AM, Sparta DR, Jennings JH, McElligott ZA, Decot H, Stuber GD (2014) Amygdala and bed nucleus of the stria terminalis circuitry: implications for addiction-related behaviors. Neuropharmacology 76:320–328. https://doi.org/10.1016/j.neuropharm.2013.05.046 pmid:23752096
    OpenUrlCrossRefPubMed
  98. ↵
    Steinberg A, Frederiksen SD, Blixt FW, Warfvinge K, Edvinsson L (2016) Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets. J Headache Pain 17:78. https://doi.org/10.1186/s10194-016-0664-3 pmid:27587062
    OpenUrlCrossRefPubMed
  99. ↵
    Stroth N, Eiden LE (2010) Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience 165:1025–1030. https://doi.org/10.1016/j.neuroscience.2009.11.023 pmid:19931358
    OpenUrlCrossRefPubMed
  100. ↵
    Suresh Nair M, Dao NC, Lopez Melean D, Griffith KR, Starnes WD, Moyer JB, Sicher AR, Brockway DF, Meeks KD, Crowley NA (2022) Somatostatin neurons in the bed nucleus of the stria terminalis play a sex-dependent role in binge drinking. Brain Res Bull 186:38–46. https://doi.org/10.1016/j.brainresbull.2022.05.010 pmid:35643257
    OpenUrlPubMed
  101. ↵
    Tanaka K, Hashimoto H, Shintani N, Yamamoto A, Baba A (2004) Reduced hypothermic and hypnotic responses to ethanol in PACAP-deficient mice. Regul Pept 123:95–98. https://doi.org/10.1016/j.regpep.2004.05.017 pmid:15518898
    OpenUrlCrossRefPubMed
  102. ↵
    Tanaka K, Kunishige-Yamamoto A, Hashimoto H, Shintani N, Hayata A, Baba A (2010) Increased ethanol preference and serotonin 1A receptor-dependent attenuation of ethanol-induced hypothermia in PACAP-deficient mice. Biochem Biophys Res Commun 391:773–777. https://doi.org/10.1016/j.bbrc.2009.11.136 pmid:19944672
    OpenUrlPubMed
  103. ↵
    Tringali G, Lavanco G, Castelli V, Pizzolanti G, Kuchar M, Currò D, Cannizzaro C, Brancato A (2023) Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene-related peptide's brain levels. Phytother Res 37:4870–4884. https://doi.org/10.1002/ptr.7972 pmid:37525534
    OpenUrlPubMed
  104. ↵
    Urban DJ, Roth BL (2015) DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 55:399–417. https://doi.org/10.1146/annurev-pharmtox-010814-124803 pmid:25292433
    OpenUrlCrossRefPubMed
  105. ↵
    Varodayan FP, Minnig MA, Steinman MQ, Oleata CS, Riley MW, Sabino V, Roberto M (2020) PACAP regulation of central amygdala GABAergic synapses is altered by restraint stress. Neuropharmacology 168:107752. https://doi.org/10.1016/j.neuropharm.2019.107752 pmid:31476352
    OpenUrlCrossRefPubMed
  106. ↵
    Weller KL, Smith DA (1982) Afferent connections to the bed nucleus of the stria terminalis. Brain Res 232:255–270. https://doi.org/10.1016/0006-8993(82)90272-4 pmid:7188024
    OpenUrlCrossRefPubMed
  107. ↵
    Wills TA, Klug JR, Silberman Y, Baucum AJ, Weitlauf C, Colbran RJ, Delpire E, Winder DG (2012) GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis. Proc Natl Acad Sci U S A 109:E278–E287. https://doi.org/10.1073/pnas.1113820109 pmid:22219357
    OpenUrlAbstract/FREE Full Text
  108. ↵
    Zamudio PA, Gioia D, Glaser C, Woodward JJ (2023) Chemogenetic perturbation of the posterior but not anterior cerebellum reduces voluntary ethanol consumption. eNeuro 10:ENEURO.0037-23.2023. https://doi.org/10.1523/ENEURO.0037-23.2023
    OpenUrl
  109. ↵
    Zhang L, Hernandez VS, Gerfen CR, Jiang SZ, Zavala L, Barrio RA, Eiden LE (2021) Behavioral role of PACAP signaling reflects its selective distribution in glutamatergic and GABAergic neuronal subpopulations. Elife 10:e61718. https://doi.org/10.7554/eLife.61718
    OpenUrlCrossRef

Synthesis

Reviewing Editor: Leandro Vendruscolo, National Institute on Drug Abuse

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Brendan Tunstall, Marsida Kallupi.

N/A

Back to top

In this issue

eneuro: 10 (12)
eNeuro
Vol. 10, Issue 12
December 2023
  • Table of Contents
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice
Lauren Lepeak, Sophia Miracle, Antonio Ferragud, Mariel P. Seiglie, Samih Shafique, Zeynep Ozturk, Margaret A. Minnig, Gianna Medeiros, Pietro Cottone, Valentina Sabino
eNeuro 1 December 2023, 10 (12) ENEURO.0424-23.2023; DOI: 10.1523/ENEURO.0424-23.2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice
Lauren Lepeak, Sophia Miracle, Antonio Ferragud, Mariel P. Seiglie, Samih Shafique, Zeynep Ozturk, Margaret A. Minnig, Gianna Medeiros, Pietro Cottone, Valentina Sabino
eNeuro 1 December 2023, 10 (12) ENEURO.0424-23.2023; DOI: 10.1523/ENEURO.0424-23.2023
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • addiction
  • alcohol
  • ethanol
  • anxiety
  • dependence
  • neuropeptide

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Release of extracellular matrix components after human traumatic brain injury
  • Action intentions reactivate representations of task-relevant cognitive cues
  • Functional connectome correlates of laterality preferences: Insights into Hand, Foot, and Eye Dominance Across the Lifespan
Show more Research Article: New Research

Disorders of the Nervous System

  • Release of extracellular matrix components after human traumatic brain injury
  • Gene variants related to primary familial brain calcification: perspectives from bibliometrics and meta-analysis
  • Expression of HDAC3-Y298H Point Mutant in Medial Habenula Cholinergic Neurons Has No Effect on Cocaine-Induced Behaviors
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.